Ryan Feaver, PhD

HemoShear Therapeutics
Charlottesville, VA, United States

Biotech / Drug Discovery

Presentation(s):

• 1145: Human Cardiovascular Disease Model Provides Transcriptomic Evidence of Cardiovascular Risk Associated with Febuxostat

  Monday, November 13, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.